Clinical Trial Update: Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia [Phase 3]

View source ↗

Summary

Phase 3 trial update for SER120 nasal spray in elderly patients with nocturia; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• SER120

Snippet

Sponsor: Serenity Pharmaceuticals, Inc. | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2020-11-17